| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |